Purchase Order FA864923P0190

Biofire Defense LLC has been awarded a $147,632.95 firm fixed price delivery order against the Department of Army Acquisition Support Center Joint PEO Chemical and Biological Defense indefinite delivery contract for software security updates. The prime contractor will provide sustainment services for the Next Generation Diagnostic System to the Army Chemical and Biological Defense organization through September 2023. No set-aside designation was used for this award. Biofire Defense...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $146,347.54 firm fixed price delivery order contract to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of a "POST ATO CYBERSECURITY IMAGE #5" under the Army's Next Generation Diagnostic System contract, which has a potential value of $18.8 million through January 2029....

This is a firm fixed price delivery order contract awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Biofire Defense LLC, a limited liability company. The contract, valued at $97,000.00, is for the provision of an "OPTIMIZED BWA ENVIRONMENTAL SURVEILLANCE" capability. Biofire Defense has previously received other federal contract and grant awards related to biological threat detection, infectious disease testing, and COVID-19 response. This contract award...

This federal contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The $123,840 firm fixed price contract is for the delivery of a non-biological warfare agent in-vitro diagnostic (IVD) assay. The contract has no set-aside designation and was completed on February 28, 2018. Biofire Defense is a manufacturer of diagnostic...

This is a delivery order contract awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of an operational biological warfare agent in vitro diagnostic (BWA IVD) assay, with a ceiling value of $85,380 and a completion date of May 15, 2017. The contract is a firm fixed-price delivery order, with no set-aside designation....

RTX BBN Technologies, Inc. was awarded a definitive contract by the Defense Threat Reduction Agency (DTRA) on October 10, 2024, for the Real-Time Analysis of Biosecurity Threats from Sequencing (RABITS) program. The $4.93M cost-plus-fixed-fee contract, with an ultimate completion date of December 30, 2027, will be performed in Cambridge, Massachusetts. This award supports DTRA's biosecurity mission by developing real-time analytical capabilities to identify and assess threats derived from...

This federal contract award, HDTRA215P0007, was made by the Defense Threat Reduction Agency (DTRA) to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The $254,100.00 firm fixed price purchase order is for a RAZR-ASY-4001 Bioterrorism Detection System with a one-year extended warranty, under Product Service Code (PSC) 6630. This award does not have a set-aside designation. Biofire Defense LLC has previously received other federal...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $688,489 delivery order to Biofire Defense LLC under an unspecified contract vehicle. The firm fixed price order is for the operational delivery of multiple biological warfare agent identification validation diagnostic assays to support Army programs. Performance will take place in Salt Lake City, Utah through June 2020. No set aside designation or subcontractors are indicated. This award...

The U.S. Department of Defense's Joint PEO Chemical and Biological Defense awarded a $131.1K delivery order to Biofire Defense LLC on July 24, 2025, for the procurement of Sentinel Panels supporting the Chemical, Biological, Radiological, and Nuclear Integrated Early Warning Office. The delivery order carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by August 29, 2025. Biofire Defense, a Salt Lake City-based molecular diagnostics manufacturer,...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $245,965.19 firm fixed price delivery order to Biofire Defense LLC, a for-profit limited liability company, for software security updates. This award is part of a larger indefinite delivery contract the Army has with Biofire Defense for sustainment of the Next Generation Diagnostic System, with a potential value of $18.8 million through January 2029. The contract does not have a set-aside...